Gastro-oesophageal Reflux Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Babies who were born full-term (between 37 and 41 weeks of pregnancy)
- Babies whose birth weight is normal for their age
- Babies who scored higher than 8 on the APGAR health check (a standard newborn assessment) at 10 minutes after birth
- Babies who had a normal physical examination at birth
- Babies whose mothers have not previously used probiotic supplements
Who may not be able to join:
- Families who are not willing to take part in the study
- Families who are unable to attend follow-up appointments until the baby reaches 1 year of age
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yong Poovorawan, MD, Center of Excellence in Clinical Virology
Phone: +66818288082
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The prevalence of functional gastrointestinal disorders in the treatment group
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.